Loading data
XPERNYSE
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 448.11 m USD | 493.69 m USD | 521.33 m USD | 502.26 m USD | 486.48 m USD |
| Research and development expense | 135.05 m USD | 191.35 m USD | 222.83 m USD | 216.36 m USD | 194.87 m USD |
| Selling, general and administrative expense | 181.87 m USD | 218.11 m USD | 233.4 m USD | 217.4 m USD | 199.92 m USD |
| Operating profit | -43.73 m USD | -87.08 m USD | -129.64 m USD | -749.43 m USD | -161.83 m USD |
| Interest expense | 2.98 m USD | 3.01 m USD | 3 m USD | 1.51 m USD | — |
| Profit before tax | -40.62 m USD | 11.58 m USD | -129.65 m USD | -747.62 m USD | -160.24 m USD |
| Income tax expense | 15.72 m USD | 12.45 m USD | 10.04 m USD | 13.59 m USD | 18.84 m USD |
| Net income (reported basis) | -56.34 m USD | -14.01 m USD | -136.61 m USD | -757.48 m USD | -175.62 m USD |
| Net income attributable to common shareholders | -56.34 m USD | -14.01 m USD | -136.61 m USD | -757.48 m USD | -175.62 m USD |
| Basic earnings per share | -1.23 USD/share | -0.31 USD/share | -3.18 USD/share | -18.02 USD/share | -4.18 USD/share |
| Diluted earnings per share | -1.23 USD/share | -0.31 USD/share | -3.18 USD/share | -18.02 USD/share | -4.18 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.